Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bug

Showing results (141-150 of 319) with videos related to

Pageof 32
Sort By:
Leukemia|August 24, 2007
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)J Dürig, S Bug, L Klein-Hitpass, et al.
Cytotherapy|March 4, 2014
Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusionEva Rettinger, Hermann Kreyenberg, Michael Merker, et al.
Annals of Hematology|August 8, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AMLAnjali Cremer, Julius C Enssle, Saskia Pfaff, et al.
Molecular Cancer Therapeutics|September 4, 2012
Breakdown of the FLT3-ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3-specific inhibitorsKristin Pietschmann, Hella Anna Bolck, Marc Buchwald, et al.
Cancer Research|April 5, 2005
Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cellsGesine Bug, Hilal Gül, Kerstin Schwarz, et al.
Journal of the American Chemical Society|September 27, 2001
Reference scales for the characterization of cationic electrophiles and neutral nucleophilesH Mayr, T Bug, M F Gotta, et al.
Infection|December 19, 2024
Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort studyJohanna Kessel, Gesine Bug, Björn Steffen, et al.
Gut|May 6, 2010
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancerS Ripka, A Neesse, J Riedel, et al.
Cancers|September 29, 2019
HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1Mandy Beyer, Annette Romanski, Al-Hassan M Mustafa, et al.
Genes & Cancer|January 9, 2015
STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AMLClaudia Oancea, Brigitte Rüster, Boris Brill, et al.
Pageof 32

Showing results (141-150 of 319) with videos related to

Sort By:
Pageof 32
Leukemia|August 24, 2007
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)J Dürig, S Bug, L Klein-Hitpass, et al.
Cytotherapy|March 4, 2014
Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusionEva Rettinger, Hermann Kreyenberg, Michael Merker, et al.
Annals of Hematology|August 8, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AMLAnjali Cremer, Julius C Enssle, Saskia Pfaff, et al.
Molecular Cancer Therapeutics|September 4, 2012
Breakdown of the FLT3-ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3-specific inhibitorsKristin Pietschmann, Hella Anna Bolck, Marc Buchwald, et al.
Cancer Research|April 5, 2005
Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cellsGesine Bug, Hilal Gül, Kerstin Schwarz, et al.
Journal of the American Chemical Society|September 27, 2001
Reference scales for the characterization of cationic electrophiles and neutral nucleophilesH Mayr, T Bug, M F Gotta, et al.
Infection|December 19, 2024
Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort studyJohanna Kessel, Gesine Bug, Björn Steffen, et al.
Gut|May 6, 2010
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancerS Ripka, A Neesse, J Riedel, et al.
Cancers|September 29, 2019
HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1Mandy Beyer, Annette Romanski, Al-Hassan M Mustafa, et al.
Genes & Cancer|January 9, 2015
STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AMLClaudia Oancea, Brigitte Rüster, Boris Brill, et al.
Pageof 32